Metformin versus insulin in the management of diabetes mellitus in pregnancy
Phase 4
Completed
- Conditions
- Diabetes Mellitus in pregnancy.Metabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12614000942651
- Lead Sponsor
- Dr. Titus Beyuo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 104
Inclusion Criteria
Pregnant with single fetus at gestational age of 20 to 30 weeks and have been diagnosed with Type 2 DM or Gestational Diabetes
Exclusion Criteria
patients with pre-gestational diabetes mellitus who require insulin to achieve glycaemic control and patients with contra-indications to metformin therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 hour blood glucose level in oral glucose tolerance test. [At baseline, one month after enrollment and at 37 weeks gestation. ]
- Secondary Outcome Measures
Name Time Method Maternal weight gain. It is measured with a calibrated analogue scale - Seca 'registered trade mark' (gmbh&Co. Kg Germany)[Baseline to 37 weeks gestation.]